Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles

Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles

US Patent 9632087 · Granted Apr 25, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Shrimp disease detection assays and uses thereof2025
Methods and kits for quantifying the removal of mock virus particles from a puri2023
Methods and kits for quantifying the removal of mock virus particles from a puri2023
PCR assays for specific detection of enterocytozoon hepatopenaei2022
Shrimp disease detection assays and uses thereof2022
Methods for evaluating viral clearance from a process solution employing mock vi2019
Methods for evaluating viral clearance from a process solution employing mock vi2019
IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and method2016
Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles exp2012
Crustacean expression vector2011